Filter Results :

Your search for Hematological returned 13 reports

Sort by


Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need

01 Aug 2017  |  Published by:  GBI Research
SummaryThe hematological disorders therapy area encompasses non-malignant disorders of the blood such as anemia, sickle cell disease, neutropenia and hemophilia. These diseases can be grouped into the three categories- red blood cell disorders, bleeding disorders and immune cell disorders - of which...

$ 6,995.00

Read More

Other Hematological Disorders-Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
SUMMARY'Other Hematological Disorders-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Other Hematological Disorders. This report p...

$ 1,250.00

Read More

Gene Therapy Hematological Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

01 Jun 2017  |  Published by:  DelveInsight
Summary Gene Therapy Hematological Disorders Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and...

$ 3,000.00

Read More

Frontier Pharma: First-in-Class Innovation in Hematological Cancers - Cytokine Signaling and Kinase Targeted Immunotherapies Dominate a Large and Highly Versatile Pipeline

03 May 2017  |  Published by:  GBI Research
SummaryThe American Cancer Society (ACS) predicts that in 2017 there will be almost 173,000 new cases of leukemia, lymphoma and myeloma, with lymphomas the most prevalent. Due to a degree of crossover between hematological malignancies in terms of their underlying pathophysiology, it is not uncommon...

$ 6,995.00

Read More

Europe Hematological Cancers Therapeutics Market Report 2017

21 Feb 2017  |  Published by:  QYResearch
Notes:Sales, means the sales volume of Hematological Cancers TherapeuticsRevenue, means the sales value of Hematological Cancers TherapeuticsThis report studies sales (consumption) of Hematological Cancers Therapeutics in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Ben...

$ 3,900.00

Read More

Europe Hematological Cancers Market Report 2017

21 Feb 2017  |  Published by:  QYResearch
Notes:Sales, means the sales volume of Hematological CancersRevenue, means the sales value of Hematological CancersThis report studies sales (consumption) of Hematological Cancers in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these c...

$ 3,900.00

Read More

Global Hematological Cancers Market Research Report 2017

01 Feb 2017  |  Published by:  QYResearch
Notes: Production, means the output of Hematological Cancers Revenue, means the sales value of Hematological CancersThis report studies Hematological Cancers in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, ...

$ 2,900.00

Read More

Global Hematological Cancers Therapeutics Market Research Report 2017

01 Feb 2017  |  Published by:  QYResearch
Notes: Production, means the output of Hematological Cancers Therapeutics Revenue, means the sales value of Hematological Cancers TherapeuticsThis report studies Hematological Cancers Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses ...

$ 2,900.00

Read More

Hematological Tumor Global Clinical Trials Review, H2, 2016

30 Oct 2016  |  Published by:  GlobalData
Summary“Hematological Tumor Global Clinical Trials Review, H2, 2016" provides an overview of Hematological Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Hematological Tumor. Report includes an overview of trial numbers and their average enrollm...

$ 2,500.00

Read More

Global Hematological Cancers Market Research Report 2016

18 Jul 2016  |  Published by:  9Dimen Research
2016 Global Advanced Distributed Management System (ADMS) Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Advanced Distributed Management System (ADMS) industry, focusing on the main regions (North America, Europe and Asia) and th...

$ 2,850.00

Read More

Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies

01 Jun 2016  |  Published by:  GBI Research
Summary Hematological malignancies are a class of cancer that affect the blood, lymph nodes and bone marrow, and include numerous forms of leukemia, lymphoma and myeloma. Hematological malignancies constituted 9% of all newly diagnosed malignancies in the US in 2011, with data indicating th...

$ 6,995.00

Read More

Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market

21 Apr 2016  |  Published by:  GBI Research
SummaryHematological malignancies are a class of cancer that affect the blood, lymph nodes and bone marrow. They include numerous forms of leukemia, lymphoma and myeloma. Hematological malignancies constituted 9% of all newly diagnosed malignancies in the US in 2011, with data indica...

$ 4,995.00

Read More

Global Non-Hematological Cancers Market to 2021 - Strong growth driven by increased uptake of low toxicity targeted treatments and versatile biologics

01 Apr 2016  |  Published by:  GBI Research
SummaryIn 2012, there were 32.6 million people living with any type of cancer within five years of diagnosis, non-hematological cancers are thought to account for 94% of global cancer prevalence. The key cancer indications of this report, namely breast, colorectal, lung and prostate ...

$ 4,995.00

Read More
Total 13 records.